Literature DB >> 1246257

Idiopathic hirsutism--an ovarian abnormality.

M A Kirschner, I R Zucker, D Jespersen.   

Abstract

We investigated increased production of testosterone and androstenedione in 44 women with unexplained adult-onset hirsutism, 41 of whom had normal-sized ovaries. Twenty women in this group had at least 50 per cent suppression of plasma testosterone and androstenedione after four to five days of dexamethasone. Testosterone and androstenedione values in ovarian-vein effluents were higher than those of their adrenal veins. We calculated adrenal secretion rates of both androgens in each patient by relating the adrenal gradients to those of cortisol. In 42 of the hirsute women, including those whose androgens were suppressed after dexamethasone, the ovaries were the predominant source of androgen production. The women with dexamethasone suppression had milder degrees of virilism and lower production rates of testosterone and androstenedione. We conclude that the ovaries are the source of excessive androgens in most women with unexplained hirsutism, and that corticoid-suppressible patients have milder forms of ovarian hyperandrogenism.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1246257     DOI: 10.1056/NEJM197603182941204

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  10 in total

1.  Hirsutism.

Authors:  G S Conway; H S Jacobs
Journal:  BMJ       Date:  1990-09-29

2.  Comparison between buserelin and dexamethasone testing in the assessment of hirsutism.

Authors:  T Re; L Barbetta; C Dall'Asta; G Faglia; B Ambrosi
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

3.  Polycystic ovary syndrome: an enigma awaiting solution.

Authors:  M Schwartz; P R Gindoff; R Jewelewicz
Journal:  Bull N Y Acad Med       Date:  1987-03

4.  Technical difficulties of selective venous blood sampling in the differential diagnosis of female hyperandrogenism.

Authors:  R Sörensen; L Moltz; U Schwartz
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

5.  Symposium on Adolescent Gynecology and Endocrinology. Part II: Secondary amenorrhea, hirsutism in adolescents and the clinical consequences of stilbestrol exposure in utero. The clinical consequences of stilbestrol exposure in utero.

Authors:  R J Kurman
Journal:  West J Med       Date:  1979-12

Review 6.  Polycystic ovary syndrome.

Authors:  J Ginsburg; C W Havard
Journal:  Br Med J       Date:  1976-09-25

7.  Changes in circulating hormone levels after ovarian wedge resection in patients with polycystic ovary syndrome.

Authors:  A Szilágyi; W Rossmanith; T Csermely; I Csaba
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

8.  The effect of laparoscopic treatment of polycystic ovarian disease by CO2-laser or Nd:YAG laser.

Authors:  G Keckstein; W Rossmanith; K Spatzier; V Schneider; K Börchers; R Steiner
Journal:  Surg Endosc       Date:  1990       Impact factor: 4.584

9.  The endocrine pattern of late onset adrenal hyperplasia (21-hydroxylase deficiency).

Authors:  E Carmina; A M Gagliano; F Rosato; M Maggiore; A Jannì
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

10.  Typical hormonal profiles are accompanied by increased immunoreactivity of theca folliculi steroid 17 alpha-hydroxylase P450 in polycystic ovary syndrome.

Authors:  K Katulski; S Bornstein; M Figiel; D Wand; A Warenik-Szymankiewicz; W H Trzeciak
Journal:  J Endocrinol Invest       Date:  1998-05       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.